DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/6lnqnh/investigation) has announced the addition of the "Investigation Report on China's Lumbrokinase Market, 2010-2019" report to their offering.
Lumbrokinase is a fibrinolytic enzyme present in the earthworm Lumbricus bimastus. Currently, it has been widely used for the prevention and treatment of cardiovascular diseases, endocrine diseases and respiratory diseases due to its efficacy of improving blood circulation.
The number of patients suffering from cardiovascular disease has kept rising to over 270 million in China by the end of 2013. With the aging population in China, the incidence of cardiovascular problems has kept rising, rendering its prevention and treatment quite important. As lumbrokinase can improve blood calculation and prevent cerebral thrombosis, it will enjoy a large market in the future. Besides, with economic development and severe environmental problems, cardiovascular diseases, endocrine diseases and respiratory diseases have reported increasing incidence, which also promotes the market demand for lumbrokinase.
Lumbrokinase boasts a large and stable market demand. According to this market survey, lumbrokinase sales in Chinese sample hospitals has dropped from CNY 54 million in 2010 to CNY 43.39 million in 2014. And in 2014, Beijing Baiao Pharmaceuticals Co., Ltd had the largest market share of about 29% for sales value.
Key Topics Covered:
1 Related Concepts of Lumbrokinase
2 Market Profile of Lumbrokinase in China
3 Survey of Lumbrokinase Sales in China, 2010-2014
4 Survey of Market Share of Major Lumbrokinase Manufacturers in China,2010-2014
5 Survey of Dosage Forms of Lumbrokinase in China, 2010-2014
6 Reference Price of Lumbrokinase in Chinese Hospitals, 2014-2015
7 Major Manufacturers of Lumbrokinase in Chinese Market, 2010-2014
8 Market Outlook of Lumbrokinase in China, 2015-2019
- Beijing Baiao Pharmaceuticals Co., Ltd
- Changchun Yuandaguoao Pharmaceutical Co., Ltd
- Jiangsu Lianhua Pharmaceutical
- Qingdao Guoda Pharmaceutical Co., Ltd
For more information visit http://www.researchandmarkets.com/research/6lnqnh/investigation